Jalal Soubhye1, Franck Meyer2, Paul Furtmüller3, Christian Obinger3, François Dufrasne1, Pierre Van Antwerpen1,4. 1. Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium. 2. Laboratory of Biopolymers & Supramolecular Nanomaterials, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Campus de la Plaine, Boulevard du Triomphe, 1050 Bruxelles, Belgium. 3. Department of Chemistry, BOKU-University of Natural Resources & Life Sciences, Vienna. 4. Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium.
Abstract
BACKGROUND: Despite its important role in the immune system, myeloperoxidase (MPO) is implicated in a wide range of inflammatory syndromes due to its oxidative product HOCl. The oxidative damages caused by MPO make it a new target for developing promising anti-inflammatory agents. In this paper, we tried to understand the mechanism of MPO inhibition in order to facilitate the drug design, to develop more accurate virtual tests and to understand the structure-activity relationship. RESULTS: Based on docking experiments, kinetic studies and in vitro tests, it is determined that a potent MPO inhibitor must possess an oxidizable group in addition to a high affinity with the active site. At last, a new hit was found in this work namely 4-(3-hydroxy-phenoxy)-butylamine (5) that has IC50 of 86 nM. CONCLUSION: Hydroxy-phenoxy alkylamine derivatives were found to be promising MPO inhibitors and they may represent an important starting point in the development of more potent MPO inhibitors.
BACKGROUND: Despite its important role in the immune system, myeloperoxidase (MPO) is implicated in a wide range of inflammatory syndromes due to its oxidative product HOCl. The oxidative damages caused by MPO make it a new target for developing promising anti-inflammatory agents. In this paper, we tried to understand the mechanism of MPO inhibition in order to facilitate the drug design, to develop more accurate virtual tests and to understand the structure-activity relationship. RESULTS: Based on docking experiments, kinetic studies and in vitro tests, it is determined that a potent MPO inhibitor must possess an oxidizable group in addition to a high affinity with the active site. At last, a new hit was found in this work namely 4-(3-hydroxy-phenoxy)-butylamine (5) that has IC50 of 86 nM. CONCLUSION:Hydroxy-phenoxy alkylamine derivatives were found to be promising MPO inhibitors and they may represent an important starting point in the development of more potent MPO inhibitors.
Entities:
Keywords:
E′; HB; SB; hydrogen bond; irreversible inhibitor; mechanism of inhibition; myeloperoxidase inhibitor; oxidizable group; reversible inhibitor; salt bridge; standard reduction potential
Authors: Jalal Soubhye; Michel Gelbcke; Pierre Van Antwerpen; François Dufrasne; Mokhtaria Yasmina Boufadi; Jean Nève; Paul G Furtmüller; Christian Obinger; Karim Zouaoui Boudjeltia; Franck Meyer Journal: ACS Med Chem Lett Date: 2016-12-02 Impact factor: 4.345